EUVIMEDEUVIMED entdecken
Crossref

A Tale of Two Responses: Vaccine vs. Natural Immunity in Young Atopic Children

Charles H Song, Yun Cheong Chang

Acta Paediatrica · 2026-12 · 115 (12) · 2717-2724

DOI: 10.1111/apa.70514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, online erschienen am 19.05.2026. Verfasst von Charles H Song und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Harbor-UCLA Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Antibodies, Bacterial, Immunity, Innate, Respiratory Tract Infections. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate baseline pneumococcal antibody levels and the influence of allergic sensitization in children under age six with recurrent respiratory infections.

Methods

We conducted a retrospective analysis of 38 fully immunised children (aged 2–5 years) with recurrent respiratory infections. Baseline serum pneumococcal antibody levels were measured against 23 serotypes. An adequate response was defined as protective levels (≥ 1.3 ug/mL) for at least 50% of tested serotypes. Associations between antibody levels and allergic sensitization (defined by skin prick test or specific IgE), asthma, and atopic dermatitis were evaluated.

Results

Inadequate baseline pneumococcal antibody levels were found in 71% of the cohort. Allergic sensitization was significantly associated with lower protective antibody levels for non‐conjugate serotypes (mean 26% vs. 51%, p = 0.04) but showed no significant correlation with conjugate vaccine serotypes. The prevalence of specific antibody deficiency was low at 5%. No significant associations were found between antibody levels and diagnosed asthma or atopic dermatitis.

Conclusion

Young children with recurrent respiratory infections frequently exhibit inadequate baseline immunity. Allergic sensitization is specifically linked to impaired responses to non‐conjugate polysaccharide antigens, suggesting atopy selectively hinders specific immune pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumococcal VaccinesAntibodies, BacterialImmunity, InnateRespiratory Tract InfectionsHumansChild, PreschoolRetrospective StudiesMaleFemaleDermatitis, Atopic

Stichwörter der Autor:innen

allergic sensitizationatopyimpaired natural immunitypneumococcal antibodiespneumococcal conjugate vaccine (PCV)pneumococcal polysaccharide vaccine 23 (PPSV23)recurrent respiratory infectionsspecific antibody deficiency

Substanzen

Pneumococcal VaccinesAntibodies, Bacterial

Autor:innen und Institutionen

  • Department of Pediatrics, Harbor-UCLA Medical Center, Los Angeles, California, USA.

Zitieren

APA

Song, C. H., & Chang, Y. C. (2026). A Tale of Two Responses: Vaccine vs. Natural Immunity in Young Atopic Children. Acta Paediatrica, 115(12), 2717-2724. https://doi.org/10.1111/apa.70514

Vancouver

Song CH, Chang YC. A Tale of Two Responses: Vaccine vs. Natural Immunity in Young Atopic Children. Acta Paediatrica. 2026;115(12):2717-2724. doi:10.1111/apa.70514

BibTeX
@article{Song2026,
  author = {Song, Charles H and Chang, Yun Cheong},
  title = {A Tale of Two Responses: Vaccine vs. Natural Immunity in Young Atopic Children},
  journal = {Acta Paediatrica},
  year = {2026},
  volume = {115},
  number = {12},
  pages = {2717--2724},
  doi = {10.1111/apa.70514}
}
Kostenlos starten →